Kanaph Therapeutics Inc. (KOSDAQ: A0082N0)
Health Care · Biotechnology · KR
₩15,540.00
+1.37% today · -69.3% 1Y
Kanaph Therapeutics Inc. (KOSDAQ: A0082N0) operates in the Biotechnology industry within the Health Care sector. The company is valued at $143.94M.
Over the last twelve months the share price has lost 69.3%, trading between 9.17K and 70.00K.
A0082N0 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $143.94M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩70,000.00
- 52-week low
- ₩9,170.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.09M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $261.11 | -1.76% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.55 | +0.07% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.84 | +0.05% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $550.39 | -0.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $823.24 | -1.24% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $147.09 | -7.39% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.